Literature DB >> 495566

Opportunistic fungal infection among cancer patients. A ten-year autopsy study.

S Y Cho, H Y Choi.   

Abstract

A high incidence of opportunistic fungal infections among cancer patients has been a pressing problem confronting clinicians. The fungal infections in 3,278 consecutive autopsies at Thomas Jefferson University Hospital during a ten-year period (1966-1975) were studied. There were 1,204 (36.7%) cancer patients; 85 (7.1%) of these patients had concomitant fungal infections. The incidence was 9.3% during the last five-year period; 5.1% during the first five-year period. Candidiasis was the most frequent fungal infection (52.2%) among these patients, followed by aspergillosis (31.1%), mucormycosis, cryptococcosis, histoplasmosis and nocardiosis. The leukemias and lymphomas were the most frequent malignancies associated with fungal infections. However, in this study, unlike others, the incidences of fungal infection in patients with some solid tumors were also high, especially those in patients with cancers of the colon and pancreas.

Entities:  

Mesh:

Year:  1979        PMID: 495566     DOI: 10.1093/ajcp/72.4.617

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  25 in total

1.  Multifactorial analysis of effects of interactions among antifungal and antineoplastic drugs on inhibition of Candida albicans growth.

Authors:  M A Ghannoum; M S Motawy; M A Abu Hatab; A S Ibrahim; R S Criddle
Journal:  Antimicrob Agents Chemother       Date:  1989-05       Impact factor: 5.191

2.  Effects of antineoplastic agents on growth, morphology and metabolism of Torulopsis glabrata.

Authors:  M A Ghannoum
Journal:  Mycopathologia       Date:  1986-09       Impact factor: 2.574

3.  Augmentation of GG2EE macrophage cell line-mediated anti-Candida activity by gamma interferon, tumor necrosis factor, and interleukin-1.

Authors:  E Blasi; S Farinelli; L Varesio; F Bistoni
Journal:  Infect Immun       Date:  1990-04       Impact factor: 3.441

4.  Cellular and cytokine correlates of mucosal protection in murine model of oral candidiasis.

Authors:  S Elahi; G Pang; R Clancy; R B Ashman
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

5.  Assay of fluconazole by megabore capillary gas-liquid chromatography with nitrogen-selective detection.

Authors:  S C Harris; J E Wallace; G Foulds; M G Rinaldi
Journal:  Antimicrob Agents Chemother       Date:  1989-05       Impact factor: 5.191

6.  Effect of antineoplastic agents and X-irradiation on the adherence of Candida spp. to human buccal epithelial cells in vitro.

Authors:  M A Ghannoum; K H Abu-Elteen; M S Motawy
Journal:  Mycopathologia       Date:  1988-12       Impact factor: 2.574

7.  Collaborative evaluation of the Abbott yeast identification system.

Authors:  B H Cooper; S Prowant; B Alexander; D H Brunson
Journal:  J Clin Microbiol       Date:  1984-06       Impact factor: 5.948

8.  Development of a LightCycler PCR assay for detection and quantification of Aspergillus fumigatus DNA in clinical samples from neutropenic patients.

Authors:  Birgit Spiess; Dieter Buchheidt; Corinna Baust; Heyko Skladny; Wolfgang Seifarth; Udo Zeilfelder; Christine Leib-Mösch; Handan Mörz; Rüdiger Hehlmann
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

9.  Early differential molecular response of a macrophage cell line to yeast and hyphal forms of Candida albicans.

Authors:  E Blasi; L Pitzurra; M Puliti; L Lanfrancone; F Bistoni
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

10.  Oral yeasts in patients with cancer of the mouth, before and during radiotherapy.

Authors:  C R Paula; M C Sampaio; E G Birman; A M Siqueira
Journal:  Mycopathologia       Date:  1990-11       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.